Font Size:
a
A
A
Keyword [Abl kinase]
Result: 1 - 20 | Page: 1 of 2
1.
The Study Of The Function Of The C-Abl Kinase In The Signaling Transduction Triggered By L-selectin Crosslinking
2.
The Establishment Of Chronic Myeloid Leukemia Cell Lines Resistant To Imatinib And The Action And Its Mechanism Of Arsenic Trioxide To Chronic Myeloid Leukemia
3.
Study Of Echinomycin On Growth Suppression In Gleveec-sensitive And Gleveec-resistence K562 Cells
4.
The Study Of The Mechanism Of The CSF-1 Gene Transcription Promoted By L-selectin Crosslinking
5.
Detection Of ABL Kinase Domain Point Mutations In Chronic Myeloid Leukemia Patients Receiving Imatinib Treatment And Research On The Clinical Correlation Of Imatinib Plasama Concentration
6.
Studay On The Affection Of C-Abl Kinase During The αvβ3 Integrin Mediated Migration Of Tumour Cell
7.
The Studies On The Function And Mechanism Of The C-Abl Kinase In Integrin α_v_β 3 Mediated Melanoma Cell Adhesion And Migration
8.
Discovery And Mechanistic Study Of Kinase Inhibitors For B Cell Related Malignancies
9.
Detection Of Abl Kinase Domain Point Mutations In Chronic Myeloid Leukemia Patients Who Develop Imatinib Resistance And Its Clinical Significance
10.
Study Of ABL Kinase Gene Polymorphism In Ph Chromosome-positive Leukemias
11.
Preliminary Studies On The Mechanism Of C-Abl Kinase Acting In MMP-2Mediated Melanoma Cell Migration
12.
Detection Of Cytogenetic And Molecular Biology In Chronic Myeloid Leukemia Patients
13.
Regulatory Mechanism Of C-Abl Kinase In β2Integrin-mediated Neutrophil Migration
14.
Theoretical Studies Of 3D-QSAR, Docking And Molecular Dynamics Simulations Studies On Abl Kinase Inhibitors
15.
Activation Of C-Abl Kinase Potentiates The Anti-myeloma Drug Lenalidomide By Promoting DDA1 Recruitment To The CRL4 Ubiquitin Ligase
16.
Analysis Of The Emergence Of ABL Kinase Domain Mutations In Chronic Myelogenous Leukemia Treated With Tyrosine Kinase Inhibitor
17.
Clinical Significance Analysis Of Chromosomal Karyotype And ABL Kinase Mutation In 194 Patients With CML
18.
The Design, Synthesis And Biological Activity Study Of Dasatinib Derivatives
19.
Analysis Of ABL Kinase Domain Mutations In The Patients With Progressive Chronic Myeloid Leukemia
20.
Abl Kinase Inhibitor STI-571 Affects The Proliferation And Apoptosis Of A375 Cells Through The PTEN-PI3K/AKT Signal Pathway
<<First
<Prev
Next>
Last>>
Jump to
